{"id":138502387,"date":"2013-06-12T00:00:00","date_gmt":"2013-06-12T04:00:00","guid":{"rendered":"https:\/\/acccapital.com\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/"},"modified":"2026-04-02T13:07:46","modified_gmt":"2026-04-02T17:07:46","slug":"biologicsmd-signs-deal-to-make-its-osteoporosis-treatment","status":"publish","type":"post","link":"https:\/\/acccapital.com\/hi\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/","title":{"rendered":"BiologicsMD Signs Deal to Make Its Osteoporosis Treatment"},"content":{"rendered":"

Fayetteville drug development startup\u00a0BiologicsMD<\/a>\u00a0announced on Tuesday a partnership with an Oklahoma firm that will make the company’s osteoporosis treatment. BioMD, which has developed what it considers a breakthrough treatment for the disease called PTH-CBD, has contracted with\u00a0Cytovance Biologics<\/a>\u00a0of Oklahoma City to develop a manufacturing platform for the drug. In addition, the firm has welcomed its newest board member, Ensysce Biosciences CEO Lynn Kirkpatrick, to help guide it through the Food and Drug Administration approval process. “We are excited to announce our partnership with Cytovance to develop the manufacturing platform for our PTH-CBD treatment,” BioMD President Paul Mlakar said in a news release. “Their expertise will play a key role in accelerating the development of this compound that will hopefully improve the lives of the millions of individuals who suffer from osteoporosis.” Click here to read the full article from Arkansas Business:\u00a0BiologicsMD Signs Deal to Make Its Osteoporosis Treatment<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Fayetteville drug development startup\u00a0BiologicsMD\u00a0announced on Tuesday a partnership with an Oklahoma firm that will make the company’s osteoporosis treatment. BioMD, which has developed what it considers a breakthrough treatment for the disease called PTH-CBD, has contracted with\u00a0Cytovance Biologics\u00a0of Oklahoma City to develop a manufacturing platform for the drug. In addition, the firm has welcomed its […]<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[109],"tags":[],"class_list":["post-138502387","post","type-post","status-publish","format-standard","category-entrepreneurship-foundation-news","entry"],"acf":[],"yoast_head":"\nBiologicsMD Signs Deal to Make Its Osteoporosis Treatment | ACC Capital<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/acccapital.com\/hi\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/\" \/>\n<meta property=\"og:locale\" content=\"hi_IN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BiologicsMD Signs Deal to Make Its Osteoporosis Treatment | ACC Capital\" \/>\n<meta property=\"og:description\" content=\"Fayetteville drug development startup\u00a0BiologicsMD\u00a0announced on Tuesday a partnership with an Oklahoma firm that will make the company’s osteoporosis treatment. BioMD, which has developed what it considers a breakthrough treatment for the disease called PTH-CBD, has contracted with\u00a0Cytovance Biologics\u00a0of Oklahoma City to develop a manufacturing platform for the drug. In addition, the firm has welcomed its […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/acccapital.com\/hi\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/\" \/>\n<meta property=\"og:site_name\" content=\"ACC Capital\" \/>\n<meta property=\"article:published_time\" content=\"2013-06-12T04:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-02T17:07:46+00:00\" \/>\n<meta name=\"author\" content=\"Isabella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Isabella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 \u092e\u093f\u0928\u091f\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/acccapital.com\\\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/acccapital.com\\\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\\\/\"},\"author\":{\"name\":\"Isabella\",\"@id\":\"https:\\\/\\\/acccapital.com\\\/#\\\/schema\\\/person\\\/0389aac25e6524c91c239e65671b6e00\"},\"headline\":\"BiologicsMD Signs Deal to Make Its Osteoporosis Treatment\",\"datePublished\":\"2013-06-12T04:00:00+00:00\",\"dateModified\":\"2026-04-02T17:07:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/acccapital.com\\\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\\\/\"},\"wordCount\":162,\"articleSection\":[\"Entrepreneurship Foundation News\"],\"inLanguage\":\"hi-IN\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/acccapital.com\\\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\\\/\",\"url\":\"https:\\\/\\\/acccapital.com\\\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\\\/\",\"name\":\"BiologicsMD Signs Deal to Make Its Osteoporosis Treatment | ACC Capital\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/acccapital.com\\\/#website\"},\"datePublished\":\"2013-06-12T04:00:00+00:00\",\"dateModified\":\"2026-04-02T17:07:46+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/acccapital.com\\\/#\\\/schema\\\/person\\\/0389aac25e6524c91c239e65671b6e00\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/acccapital.com\\\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\\\/#breadcrumb\"},\"inLanguage\":\"hi-IN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/acccapital.com\\\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/acccapital.com\\\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/acccapital.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BiologicsMD Signs Deal to Make Its Osteoporosis Treatment\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/acccapital.com\\\/#website\",\"url\":\"https:\\\/\\\/acccapital.com\\\/\",\"name\":\"ACC Capital\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/acccapital.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"hi-IN\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/acccapital.com\\\/#\\\/schema\\\/person\\\/0389aac25e6524c91c239e65671b6e00\",\"name\":\"Isabella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hi-IN\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0cc82874b1e0a13a2154832ea73741ab9898a86fc54065bbfb5fdc16fbc7e4b2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0cc82874b1e0a13a2154832ea73741ab9898a86fc54065bbfb5fdc16fbc7e4b2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/0cc82874b1e0a13a2154832ea73741ab9898a86fc54065bbfb5fdc16fbc7e4b2?s=96&d=mm&r=g\",\"caption\":\"Isabella\"},\"url\":\"https:\\\/\\\/acccapital.com\\\/hi\\\/author\\\/ibarnelloacccapital-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BiologicsMD Signs Deal to Make Its Osteoporosis Treatment | ACC Capital","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/acccapital.com\/hi\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/","og_locale":"hi_IN","og_type":"article","og_title":"BiologicsMD Signs Deal to Make Its Osteoporosis Treatment | ACC Capital","og_description":"Fayetteville drug development startup\u00a0BiologicsMD\u00a0announced on Tuesday a partnership with an Oklahoma firm that will make the company’s osteoporosis treatment. BioMD, which has developed what it considers a breakthrough treatment for the disease called PTH-CBD, has contracted with\u00a0Cytovance Biologics\u00a0of Oklahoma City to develop a manufacturing platform for the drug. In addition, the firm has welcomed its […]","og_url":"https:\/\/acccapital.com\/hi\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/","og_site_name":"ACC Capital","article_published_time":"2013-06-12T04:00:00+00:00","article_modified_time":"2026-04-02T17:07:46+00:00","author":"Isabella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Isabella","Est. reading time":"1 \u092e\u093f\u0928\u091f"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/acccapital.com\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/#article","isPartOf":{"@id":"https:\/\/acccapital.com\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/"},"author":{"name":"Isabella","@id":"https:\/\/acccapital.com\/#\/schema\/person\/0389aac25e6524c91c239e65671b6e00"},"headline":"BiologicsMD Signs Deal to Make Its Osteoporosis Treatment","datePublished":"2013-06-12T04:00:00+00:00","dateModified":"2026-04-02T17:07:46+00:00","mainEntityOfPage":{"@id":"https:\/\/acccapital.com\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/"},"wordCount":162,"articleSection":["Entrepreneurship Foundation News"],"inLanguage":"hi-IN"},{"@type":"WebPage","@id":"https:\/\/acccapital.com\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/","url":"https:\/\/acccapital.com\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/","name":"BiologicsMD Signs Deal to Make Its Osteoporosis Treatment | ACC Capital","isPartOf":{"@id":"https:\/\/acccapital.com\/#website"},"datePublished":"2013-06-12T04:00:00+00:00","dateModified":"2026-04-02T17:07:46+00:00","author":{"@id":"https:\/\/acccapital.com\/#\/schema\/person\/0389aac25e6524c91c239e65671b6e00"},"breadcrumb":{"@id":"https:\/\/acccapital.com\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/#breadcrumb"},"inLanguage":"hi-IN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/acccapital.com\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/acccapital.com\/biologicsmd-signs-deal-to-make-its-osteoporosis-treatment\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/acccapital.com\/"},{"@type":"ListItem","position":2,"name":"BiologicsMD Signs Deal to Make Its Osteoporosis Treatment"}]},{"@type":"WebSite","@id":"https:\/\/acccapital.com\/#website","url":"https:\/\/acccapital.com\/","name":"ACC Capital","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/acccapital.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"hi-IN"},{"@type":"Person","@id":"https:\/\/acccapital.com\/#\/schema\/person\/0389aac25e6524c91c239e65671b6e00","name":"Isabella","image":{"@type":"ImageObject","inLanguage":"hi-IN","@id":"https:\/\/secure.gravatar.com\/avatar\/0cc82874b1e0a13a2154832ea73741ab9898a86fc54065bbfb5fdc16fbc7e4b2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0cc82874b1e0a13a2154832ea73741ab9898a86fc54065bbfb5fdc16fbc7e4b2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0cc82874b1e0a13a2154832ea73741ab9898a86fc54065bbfb5fdc16fbc7e4b2?s=96&d=mm&r=g","caption":"Isabella"},"url":"https:\/\/acccapital.com\/hi\/author\/ibarnelloacccapital-com\/"}]}},"_links":{"self":[{"href":"https:\/\/acccapital.com\/hi\/wp-json\/wp\/v2\/posts\/138502387","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acccapital.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/acccapital.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/acccapital.com\/hi\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/acccapital.com\/hi\/wp-json\/wp\/v2\/comments?post=138502387"}],"version-history":[{"count":1,"href":"https:\/\/acccapital.com\/hi\/wp-json\/wp\/v2\/posts\/138502387\/revisions"}],"predecessor-version":[{"id":138503447,"href":"https:\/\/acccapital.com\/hi\/wp-json\/wp\/v2\/posts\/138502387\/revisions\/138503447"}],"wp:attachment":[{"href":"https:\/\/acccapital.com\/hi\/wp-json\/wp\/v2\/media?parent=138502387"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acccapital.com\/hi\/wp-json\/wp\/v2\/categories?post=138502387"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/acccapital.com\/hi\/wp-json\/wp\/v2\/tags?post=138502387"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}